Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Florence Anthony A. Jr.
Relationship:  
City:   Chevy Chase
State:   MD
   
Insider Summary:
  
   
Companies Owned :   36    
Direct Shares   3,512,542    

Indirect Shares

   284,402,988      
Direct Value   $72,544    

Indirect Value

   $570,119,902      
Total Shares   287,915,530      
Total Value   $570,192,446      


Mersana Therapeutics, Inc. $8,763 Appian Corp $63,781 Mirum Pharmaceuticals, Inc. $0 Enliven Therapeutics Ord Shs $0 Mersana Therapeutics, Inc. $8,763 Appian Corp $63,781 Mirum Pharmaceuticals, Inc. $0 Enliven Therapeutics Ord Shs $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    5   
    3    

     Stock price went up :
    3   
    1    
     Stock price went down :
    2   
    2    
   
     Gain/Loss Ratio :
   1.5   
   1.5   
     Percentage Gain/Loss :
   38.2%
 148.6%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Interleukin Genetics Inc ILIU 10% Owner 0 2016-07-29 55,418,811    Premium*  
            Loxo Oncology, Inc. LOXO 10% Owner 2014-08-06 0 2014-08-06 1,789,420    Premium*  
            Tracon Pharmaceuticals, Inc. TCON 10% Owner 2015-02-04 0 2016-11-29 2,758,039    Premium*  
            Champions Biotechnology Inc CSBR 10% Owner 0 2015-03-11 18,750,000    Premium*  
            Ardelyx Inc ARDX 10% Owner 0 2019-12-09 6,564,372    Premium*  
            Nuvelo Inc ABIO 10% Owner 0 2018-02-26 0    Premium*  
            Synlogic Inc SYBX 10% Owner 2015-10-05 0 2018-01-26 4,228,940    Premium*  
            Avalo Therapeutics, Inc AVTX 10% Owner 2015-10-20 0 2015-10-20 594,245    Premium*  
            Adaptimmune Therapeutics PLC ADAP 10% Owner 0 2020-01-24 102,478,668    Premium*  
            Aveo Pharmaceuticals Inc AVEO 10% Owner 0 2022-10-19 354    Premium*  
            Achaogen Inc AKAO 10% Owner 0 2016-12-19 5,215,128    Premium*  
            Cascadian Therapeutics, Inc CASC 10% Owner 0 2018-03-09 0    Premium*  
            Mulesoft, Inc MULE 10% Owner 0 2018-05-01 0    Premium*  
            Mersana Therapeutics, Inc. MRSN 10% Owner 2020-09-14 3,210 2020-09-14 10,260    Premium*  
            Regulus Therapeutics Inc. RGLS 10% Owner 0 2020-12-04 6,451,056    Premium*  
            Surface Oncology, Inc. SURF 10% Owner 2018-04-23 0 2018-04-23 3,312,877    Premium*  
            Appian Corp APPN 10% Owner 2018-02-13 1,924 2018-02-13 13,895    Premium*  
            Genocea Biosciences, Inc. GNCA 10% Owner 2019-02-14 0 2022-05-25 0    Premium*  
            Trevi Therapeutics, Inc. TRVI 10% Owner 2019-05-09 0 2022-04-11 948,948    Premium*  
            Mirum Pharmaceuticals, Inc. MIRM 10% Owner 2023-06-13 384 2023-06-13 11,348    Premium*  
            Casper Sleep Inc. CSPR Director, 10% Owner 2022-01-25 0 2022-01-25 0    Premium*  
            Akouos, Inc. AKUS 10% Owner 2020-06-30 0 2022-11-30 0    Premium*  
            Nkarta, Inc. NKTX 10% Owner 2020-07-14 0 2020-07-14 2,902,115    Premium*  
            Inozyme Pharma, Inc. INZY 10% Owner 2020-07-28 0 2020-07-28 2,437,689    Premium*  
            Metacrine, Inc. MTCR 10% Owner 2020-09-18 0 2021-12-22 2,563,257    Premium*  
            Eargo, Inc. EAR 10% Owner 2020-10-20 0 2021-05-24 0    Premium*  
            Desktop Metal Ord Shs Class A DM 10% Owner 0 2021-06-08 806    Premium*  
            Savara Inc SVRA 10% Owner 0 2023-07-17 24,471,264    Premium*  
            Marker Therapeutics Inc MRKR 10% Owner 2021-03-16 0 2021-03-16 10,714,285    Premium*  
            Bright Health Group Inc. BHG 10% Owner 0 2021-06-28 23,983,073    Premium*  
            Monte Rosa Therapeutics, Inc. GLUE 10% Owner 2021-06-28 0 2021-06-28 7,692,298    Premium*  
            Robinhood Markets, Inc. HOOD Director 2021-08-02 0 2022-05-03 0    Premium*  
            Enliven Therapeutics Ord Shs ELVN 10% Owner 2022-01-06 3,507,024 2021-12-30 0    Premium*  
            Ionq Ord Shs IONQ 10% Owner 2022-11-16 0 2022-11-16 1,047    Premium*  
            Arcellx, Inc. ACLX 10% Owner 2022-12-20 0 2022-12-21 0    Premium*  
            Korro Bio KRRO 0 2024-04-22 1,090,793    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ADAP Adaptimmune Therapeutics ... 10% Owner   –       –       •   2018-03-27 4 B $1.92 $11,500,200 I/I 6,000,000 79,978,672 1.5 -
ADAP Adaptimmune Therapeutics ... 10% Owner   –       –       •   2018-03-26 4 B $1.90 $1,087,553 I/I 571,164 73,978,672 1.5 -
ADAP Adaptimmune Therapeutics ... 10% Owner   –       –       •   2018-03-23 4 B $1.95 $572,358 I/I 294,090 73,407,508 1.5 -
ADAP Adaptimmune Therapeutics ... 10% Owner   –       –       •   2018-03-22 4 B $1.90 $1,655,669 I/I 869,574 73,113,418 1.5 -
ADAP Adaptimmune Therapeutics ... 10% Owner   –       –       •   2018-03-21 4 B $1.81 $189,820 I/I 104,844 72,243,844 1.5 -
ADAP Adaptimmune Therapeutics ... 10% Owner   –       –       •   2017-03-27 4 B $0.70 $9,009,000 I/I 12,870,000 72,139,000 1.5 -
ADAP Adaptimmune Therapeutics ... 10% Owner   –       –       •   2016-01-01 3 IO $0.00 $0 I/I 0 59,269,000 -
ILIU Interleukin Genetics Inc 10% Owner   –       –       •   2016-07-29 4 B $0.10 $2,000,000 I/I 20,120,724 55,418,811 1.5 -
BHG Bright Health Group Inc. 10% Owner   –       –       •   2021-06-24 3 IO $0.00 $0 I/I 0 46,859,421 -
ILIU Interleukin Genetics Inc 10% Owner   –       –       •   2014-12-23 4 B $0.10 $1,992,857 I/I 19,868,965 35,298,087 1.5 -
GNCA Genocea Biosciences, Inc. 10% Owner   –       –       •   2019-02-14 4 B $0.47 $4,688,619 I/I 9,948,269 34,948,269 1.5 -
DM Desktop Metal Ord Shs Cla... 10% Owner   –       –       •   2020-12-09 3 IO $0.00 $0 I/I 0 28,398,927 -
AVEO Aveo Pharmaceuticals Inc 10% Owner   –       –       •   2019-04-08 4 B $1.14 $4,956,523 I/I 4,347,827 25,243,865 1.5 -
SVRA Savara Inc 10% Owner   –       –       •   2023-07-17 4 B $3.00 $999,999 I/I 333,333 24,471,264 1.5 %
SVRA Savara Inc 10% Owner   –       –       •   2021-03-15 3 IO $0.00 $0 I/I 0 24,137,931 %
BHG Bright Health Group Inc. 10% Owner   –       –       •   2021-06-28 4 B $18.00 $34,999,992 I/I 1,944,444 23,983,073 1.5 %
BHG Bright Health Group Inc. 10% Owner   –       –       •   2021-06-28 4 A $0.00 $0 I/I 133,640,415 22,288,629 0 -
AVEO Aveo Pharmaceuticals Inc 10% Owner   –       –       •   2018-12-21 4 B $1.49 $448,380 I/I 300,000 20,896,038 1.5 -
AVEO Aveo Pharmaceuticals Inc 10% Owner   –       –       •   2018-12-20 4 B $1.63 $326,060 I/I 200,000 20,596,038 1.5 -
AVEO Aveo Pharmaceuticals Inc 10% Owner   –       –       •   2018-12-11 4 B $1.98 $121,084 I/I 61,200 20,396,038 1.5 -
AVEO Aveo Pharmaceuticals Inc 10% Owner   –       –       •   2018-12-10 4 B $1.98 $51,576 I/I 26,000 20,334,838 1.5 -
AVEO Aveo Pharmaceuticals Inc 10% Owner   –       –       •   2018-12-07 4 B $1.98 $232,362 I/I 117,100 20,308,838 1.5 -
AVEO Aveo Pharmaceuticals Inc 10% Owner   –       –       •   2018-12-06 4 B $1.99 $54,414 I/I 27,300 20,191,738 1.5 -
AVEO Aveo Pharmaceuticals Inc 10% Owner   –       –       •   2018-11-30 4 B $1.98 $142,067 I/I 71,900 20,164,438 1.5 -
AVEO Aveo Pharmaceuticals Inc 10% Owner   –       –       •   2018-11-28 4 B $1.99 $48,824 I/I 24,500 20,092,538 1.5 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us